Latest PTCT reports update at 2024-04-25: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. PTC Therapeutics
  4. Financial Ratios
PTC Therapeutics logo
PTC Therapeutics PTCT
$ 31.05 -0.29%
mail-toReport an Error

PTC Therapeutics Financial Ratios 2011-2024 | PTCT

Annual Financial Ratios PTC Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -3.4 -5.8 -4.7 -8.6 -12.0 -10.9 -13.2 -2.9 -4.7 -18.5 -6.7 - -

P/S

 2.3 4.6 4.6 9.9 9.8 5.3 5.4 5.0 21.8 75.5 11.0 - -

EPS

 -8.4 -7.8 -7.4 -6.6 -4.3 -2.8 -2.0 -4.2 -5.1 -3.0 -5.2 219.8 23.9

EV (Enterprise Value)

 4.25 B 5.02 B 4.21 B 5.28 B 3.76 B 1.99 B 1.17 B 507 M 885 M 1.72 B 344 M 29.5 M 254 M

EBITDA per Share

 -2.71 -4.44 -4.4 -5.88 -2.81 -1.58 -1.25 -3.78 -4.88 -3.08 -3.35 - -

EV/EBITDA

 -13.6 -11.2 -18.4 -18.7 -22.1 -3.5 -5.1 -17.3 -7.6 - -

PEG

 -0.14 -0.15 -0.19 -0.35 0.22 0.3 -0.26 -0.16 0.07 -0.43 0.04 - -

P/B

 -2.6 -9.4 1721.0 7.8 5.1 4.0 6.7 3.5 3.5 5.8 2.5 - -

P/CF

 -13.4 -9.1 -9.8 -19.4 -20.9 -32.3 -79.4 -3.9 -6.3 -28.0 -7.2 - -

ROE %

 76.55 161.06 -36432.61 -90.91 -42.33 -36.52 -50.50 -118.84 -75.42 -31.41 -37.77 - -

ROA %

 -33.05 -32.78 -27.03 -19.84 -15.49 -11.44 -20.17 -52.76 -46.31 -28.14 -33.95 - -

ROCE %

 53.69 128.90 -26039.15 -89.58 -13.89 -10.12 -20.77 -60.10 -51.80 -33.06 -32.71 - -

Current Ratio

 0.7 0.8 1.0 1.3 3.3 1.9 3.0 5.3 7.8 10.0 11.0 - -

DSO

 61.6 69.5 61.1 60.1 66.0 93.6 75.8 110.0 110.1 70.7 11.2 - -

DIO

 - - - - 580.1 464.3 857.6 - - - - - -

DPO

 - - - - 310.5 172.9 1218.7 - - - - - -

Operating Cycle

 61.6 69.5 61.1 60.1 646.1 557.9 933.4 - - - - - -

Cash Conversion Cycle

 61.6 69.5 61.1 60.1 335.6 385.1 -285.2 - - - - - -

All numbers in USD currency

Quarterly Financial Ratios PTC Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -1.2 - -1.76 -2.66 -1.88 - -1.53 -2.13 -1.78 - -1.89 -1.68 -1.83 -1.08 -1.03 -2.78 -1.81 -1.37 -1.06 -0.75 -1.29 0.96 -1.06 -0.21 -0.46 0.03 -0.82 -0.44 -0.85 -0.78 -1.03 -1.14 -1.22 -1.5 -1.27 -1.14 -1.15 -0.84 -0.93 -0.86 -0.58 -0.75 -0.19 -5.51 -6527.3 -1380.13 -1605.53 168 -5992.61 - - - -

EBITDA per Share

 0.13 - -0.79 -2.17 -1.01 - -0.52 -0.93 -0.85 - -0.68 -1.22 -1.2 -1.38 -0.36 -2.58 -1.34 -1.18 -0.67 -0.43 -1.11 -0.89 -0.6 0.14 -0.26 0.13 -0.46 -0.28 -0.75 -0.73 -0.87 -1.03 -1.11 -1.42 -1.18 -1.11 -1.13 -0.98 -0.88 -0.83 -0.56 -0.76 -0.1 -5 -1.76 K -1.33 K -1.1 K -1.98 K - - - - -

ROE %

 84.22 84.53 132.70 161.06 210.19 271.54 144.19 -31.33 -175.01 -231.54 -246.96 -134.07 -111.50 -90.91 -88.55 -84.19 -53.58 -42.33 -43.04 -47.48 -43.16 -36.52 -21.93 -28.96 -37.42 -50.50 -73.72 -81.56 -102.93 -118.84 -118.97 -108.69 -93.12 -75.42 -62.01 -52.03 -43.46 -31.41 -35.37 -29.47 -31.74 -37.77 -18.38 -7.82 8.95 19.71 13.41 6.09 - - - - -

ROA %

 -41.09 -34.05 -40.99 -37.37 -29.55 -21.02 -27.68 -20.36 -26.11 -18.50 -21.86 -18.36 -20.83 -19.84 -21.26 -21.80 -16.16 -15.49 -15.03 -15.89 -14.16 -11.44 -6.80 -10.86 -14.47 -20.17 -30.44 -34.89 -44.87 -52.76 -56.76 -55.54 -51.59 -46.66 -40.90 -37.25 -34.28 -28.14 -31.73 -26.45 -28.52 -33.95 -70.16 -123.07 -159.89 -150.22 -102.24 -46.42 - - - - -

ROCE %

 76.49 79.49 109.54 121.98 136.49 176.26 87.55 -31.21 -132.00 -172.36 -192.35 -115.08 -103.83 -89.58 -81.83 -80.57 -48.24 -40.58 -41.20 -44.78 -39.84 -32.98 -16.63 -22.63 -29.02 -41.10 -65.48 -72.55 -95.13 -110.43 -110.86 -102.73 -89.25 -73.95 -63.42 -53.98 -45.39 -33.31 -35.76 -29.64 -31.73 -33.25 -13.94 -3.73 14.38 20.66 14.61 7.53 - - - - -

Current Ratio

 0.7 0.7 0.7 0.7 0.8 0.8 0.9 - 0.9 1.0 1.1 1.1 1.2 1.3 1.3 1.3 1.3 1.6 1.6 1.6 1.6 1.5 1.5 1.5 1.5 1.7 1.7 1.7 1.7 1.8 1.8 1.8 1.8 2.6 2.6 2.6 2.6 9.6 9.6 9.6 9.6 9.9 9.9 9.9 9.9 0.4 0.4 0.4 - - - - -

DSO

 77.8 - 79.7 81.0 74.0 - 26.1 38.9 77.2 - 57.7 67.6 63.5 - 53.9 84.8 83.9 - 71.0 59.3 105.1 72.2 115.6 90.1 88.1 63.6 88.1 76.8 112.3 - 99.0 145.5 87.0 - 103.5 149.4 94.8 - 239.4 241.9 26.8 9.9 - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - 585.4 548.0 679.8 - 446.7 571.8 402.6 - 620.3 1294.6 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - 313.4 293.4 313.5 - 166.3 212.9 318.9 - 881.5 1839.7 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 77.8 - 79.7 81.0 74.0 - 26.1 38.9 77.2 - 57.7 67.6 63.5 - 53.9 84.8 83.9 - 656.4 607.3 784.9 72.2 562.4 661.9 490.8 63.6 708.4 1371.4 112.3 - 99.0 145.5 87.0 - 103.5 149.4 94.8 - 239.4 241.9 26.8 9.9 - - - - - - - - - - -

Cash Conversion Cycle

 77.8 - 79.7 81.0 74.0 - 26.1 38.9 77.2 - 57.7 67.6 63.5 - 53.9 84.8 83.9 - 343.0 313.9 471.4 72.2 396.0 449.0 171.9 63.6 -173.1 -468.2 112.3 - 99.0 145.5 87.0 - 103.5 149.4 94.8 - 239.4 241.9 26.8 9.9 - - - - - - - - - - -

All numbers in USD currency